(Q30307673)

16 June 2017

title

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells (English)

1 reference

16 June 2017

Everett AD

1

1 reference

16 June 2017

Stoops T

series ordinal

2

1 reference

16 June 2017

McNamara CA

series ordinal

3

1 reference

16 June 2017

language of work or name

English

0 references

publication date

31 July 2001

1 reference

Journal of Biological Chemistry

16 June 2017

published in

1 reference

16 June 2017

volume

276

1 reference

16 June 2017

issue

40

1 reference

16 June 2017

page(s)

37564-37568

1 reference

Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Modulation of growth factor action: implications for the treatment of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Direct effect of basic fibroblast growth factor on gene transcription in a cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Nuclear targeting sequences--a consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

An endothelial growth factor involved in rat renal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Hepatoma-derived growth factor belongs to a gene family in mice showing significant homology in the amino terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Substrates for p34cdc2: in vivo veritas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105109200

21 January 2018

Identifiers

DOI

10.1074/JBC.M105109200

1 reference

16 June 2017

1 reference